American Well (NYSE:AMWL) Trading 2.7% Higher - Here's What Happened

Key Points

• American Well's stock price increased by 2.7% on Monday, closing at $5.60 after previously trading even higher, with trading volume up 24% from average levels.
• Despite the recent stock movement, Weiss Ratings reiterated a "sell" rating, and Wells Fargo lowered its price target from $15.00 to $12.00, reflecting ongoing concerns about the company's performance.
• In Q2, American Well reported earnings of ($1.24) EPS against expectations of ($1.84), with significant revenues of $70.90 million, although the company suffers from a negative net margin of 46.15%.

American Well Corporation (NYSE:AMWL - Get Free Report)'s share price traded up 2.7% on Monday . The stock traded as high as $5.68 and last traded at $5.60. 111,409 shares changed hands during mid-day trading, an increase of 24% from the average session volume of 90,082 shares. The stock had previously closed at $5.45.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of American Well in a report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on shares of American Well from $15.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $9.17.

American Well Price Performance

The stock's 50-day moving average price is $6.54 and its 200 day moving average price is $7.14. The firm has a market cap of $90.42 million, a P/E ratio of -0.69 and a beta of 1.26.

American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($1.24) EPS for the quarter, topping analysts' consensus estimates of ($1.84) by $0.60. The business had revenue of $70.90 million for the quarter, compared to analyst estimates of $63.87 million. American Well had a negative net margin of 46.15% and a negative return on equity of 41.99%. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts forecast that American Well Corporation will post -9.34 EPS for the current fiscal year.

Insiders Place Their Bets

In other American Well news, insider Dmitry Zamansky sold 25,605 shares of the company's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $6.77, for a total transaction of $173,345.85. Following the sale, the insider directly owned 197,711 shares of the company's stock, valued at approximately $1,338,503.47. This represents a 11.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Deborah C. Jackson sold 4,531 shares of the company's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $6.56, for a total transaction of $29,723.36. Following the sale, the director directly owned 39,132 shares in the company, valued at $256,705.92. This trade represents a 10.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,383 shares of company stock valued at $331,514. 12.80% of the stock is currently owned by corporate insiders.

Institutional Trading of American Well

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMWL. Headlands Technologies LLC bought a new stake in American Well during the second quarter worth $39,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of American Well in the second quarter valued at about $89,000. Engineers Gate Manager LP bought a new position in shares of American Well in the second quarter valued at about $101,000. JPMorgan Chase & Co. raised its position in shares of American Well by 16.5% in the second quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock valued at $131,000 after purchasing an additional 2,081 shares during the period. Finally, Corton Capital Inc. raised its position in shares of American Well by 71.7% in the second quarter. Corton Capital Inc. now owns 27,402 shares of the company's stock valued at $244,000 after purchasing an additional 11,445 shares during the period. 56.05% of the stock is owned by institutional investors.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.